Simplex Trading’s 89bio ETNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-256,200
| Closed | -$3.77M | – | 8951 |
|
|
2025
Q3 | $3.77M | Buy |
256,200
+230,400
| +893% | +$2.35M | ﹤0.01% | 1724 |
|
|
2025
Q2 | $253K | Buy |
25,800
+11,700
| +83% | +$96.9K | ﹤0.01% | 4253 |
|
|
2025
Q1 | $102K | Buy |
14,100
+2,200
| +18% | +$19.2K | ﹤0.01% | 5031 |
|
|
2024
Q4 | $93K | Buy |
11,900
+500
| +4% | +$4.12K | ﹤0.01% | 5236 |
|
|
2024
Q3 | $84K | Buy |
11,400
+1,400
| +14% | +$11.8K | ﹤0.01% | 5402 |
|
|
2024
Q2 | $80K | Sell |
10,000
-36,300
| -78% | -$324K | ﹤0.01% | 5603 |
|
|
2024
Q1 | $538K | Sell |
46,300
-55,400
| -54% | -$613K | ﹤0.01% | 3784 |
|
|
2023
Q4 | $1.14M | Buy |
101,700
+50,200
| +97% | +$461K | ﹤0.01% | 2897 |
|
|
2023
Q3 | $795K | Sell |
51,500
-58,200
| -53% | -$977K | ﹤0.01% | 2901 |
|
|
2023
Q2 | $2.08M | Sell |
109,700
-47,600
| -30% | -$836K | ﹤0.01% | 1950 |
|
|
2023
Q1 | $2.4M | Buy |
157,300
+154,200
| +4,974% | +$2.01M | ﹤0.01% | 1794 |
|
|
2022
Q4 | $39K | Sell |
3,100
-4,600
| -60% | -$41.4K | ﹤0.01% | 6171 |
|
|
2022
Q3 | $44K | Buy |
+7,700
| New | +$33.8K | ﹤0.01% | 6619 |
|
|
2021
Q2 | – | Sell |
-1
| Closed | -$2K | – | 10192 |
|
|
2021
Q1 | $2K | Buy |
+1
| New | +$23 | ﹤0.01% | 8448 |
|
Other funds holding ETNB
Simplex Trading's ETNB Position: Q4 2025 in Review
Simplex Trading sold out of 89bio (ETNB) in Q4 2025, closing a stake of 108,245 shares — an estimated $1.59M sold.
Simplex Trading first reported a position in ETNB in Q1 2021 and held it in 15 quarters. The position peaked at $2.4M in Q1 2023. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.
- Simplex Trading reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
- Simplex Trading sold 108,245 89bio shares in Q4 2025, an estimated $1.59M.
- Simplex Trading first reported a position in 89bio in Q1 2021 and held it in 15 quarters.
- Simplex Trading's 89bio position peaked at $2.4M in Q1 2023.
- 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.
Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.